Correlation Between Sonata Software and Akums Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonata Software and Akums Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonata Software and Akums Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonata Software Limited and Akums Drugs and, you can compare the effects of market volatilities on Sonata Software and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonata Software with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonata Software and Akums Drugs.

Diversification Opportunities for Sonata Software and Akums Drugs

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Sonata and Akums is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Sonata Software Limited and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and Sonata Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonata Software Limited are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of Sonata Software i.e., Sonata Software and Akums Drugs go up and down completely randomly.

Pair Corralation between Sonata Software and Akums Drugs

Assuming the 90 days trading horizon Sonata Software Limited is expected to generate 0.8 times more return on investment than Akums Drugs. However, Sonata Software Limited is 1.25 times less risky than Akums Drugs. It trades about 0.08 of its potential returns per unit of risk. Akums Drugs and is currently generating about -0.07 per unit of risk. If you would invest  50,089  in Sonata Software Limited on August 30, 2024 and sell it today you would earn a total of  13,436  from holding Sonata Software Limited or generate 26.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy65.04%
ValuesDaily Returns

Sonata Software Limited  vs.  Akums Drugs and

 Performance 
       Timeline  
Sonata Software 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonata Software Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Sonata Software is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Akums Drugs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sonata Software and Akums Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonata Software and Akums Drugs

The main advantage of trading using opposite Sonata Software and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonata Software position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.
The idea behind Sonata Software Limited and Akums Drugs and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Valuation
Check real value of public entities based on technical and fundamental data
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies